Nuvectis Pharma, Inc. NVCT Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Nuvectis Pharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Nuvectis Pharma, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nuvectis Pharma, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nuvectis Pharma, Inc.'s operating cash flow?
- Nuvectis Pharma, Inc. (NVCT) reported operating cash flow of -$6.51M in Q1 2026.
- How has Nuvectis Pharma, Inc.'s operating cash flow changed year-over-year?
- Nuvectis Pharma, Inc.'s operating cash flow decreased by 56.0% year-over-year, from -$4.17M to -$6.51M.
- What is the long-term trend for Nuvectis Pharma, Inc.'s operating cash flow?
- Over 3 years (2022 to 2025), Nuvectis Pharma, Inc.'s operating cash flow has grown at a 5.7% compound annual growth rate (CAGR), from -$13.56M to -$16.01M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.